scholarly journals Short- and Long-Term Risk Stratification in Acute Coronary Syndromes

2006 ◽  
Vol 48 (5) ◽  
pp. 939-947 ◽  
Author(s):  
Cynthia M. Westerhout ◽  
Yuling Fu ◽  
Michael S. Lauer ◽  
Stefan James ◽  
Paul W. Armstrong ◽  
...  
1970 ◽  
Vol 110 (4) ◽  
pp. 77-80
Author(s):  
M. R. Babarskiene ◽  
J. Vencloviene ◽  
D. Luksiene ◽  
I. Milvidaite

Ischemic heart disease is the leading cause of death in Europe among males over 45 years of age and females older than 65. The aim of the study: to evaluate the informative value of the models in ACS patients using GRACE (GR) risk score, to identify additional informative indicators for short-term and long-term prognosis following ACS, and to evaluate the prognostic reliability of the integrated model. The study included 1491 patients who in 2005 were treated for ACS in the Department of Cardiology, the Hospital of Kaunas University of Medicine. We devised an adjusted prognostic index for making short and long-term prognosis in patients with acute coronary syndromes (STEMI and NSETMI). Following adjustment of the GR scores, the prognostic value improved for STEMI patients. Ill. 2, bibl. 12, tabl. 3 (in English; abstracts in English and Lithuanian).http://dx.doi.org/10.5755/j01.eee.110.4.292


2001 ◽  
Vol 38 (1) ◽  
pp. 56-63 ◽  
Author(s):  
Ian C Marschner ◽  
David Colquhoun ◽  
R.John Simes ◽  
Paul Glasziou ◽  
Philip Harris ◽  
...  

2010 ◽  
Vol 3 (4) ◽  
pp. 308-316 ◽  
Author(s):  
Alexandra J. Lansky ◽  
Kenji Goto ◽  
Ecaterina Cristea ◽  
Martin Fahy ◽  
Helen Parise ◽  
...  

2005 ◽  
Vol 94 (11) ◽  
pp. 926-932 ◽  
Author(s):  
Rudolf Jarai ◽  
Johann Wojta ◽  
Kurt Huber

SummaryFifty percent of patients who experience death or develop heart failure after acute coronary syndromes (ACS) have extremely elevated concentrations of plasma B-type natriuretic peptides. These elevations, however, seem not to reflect permanent ventricular dysfunction or heart failure and are assumed to exist already at the onset of ischemic symptoms. The underlying mechanisms of BNP/Nt-proBNP elevations in patients withACS are still not known at present. Furthermore, the relationship of elevated BNP/Nt-proBNP with mortality but not with atherothrombotic complications of underlying disease makes it difficult to choose optimal therapeutic strategies based on plasma levels of these peptides. The remarkably high short- and long-term mortality rate associated with increases of BNP/Nt-proBNP elevations clearly show the need of further investigation to focus on this high-risk group of patients in order to clarify underlying pathomechanisms and to find optimal therapeutic approaches.


Sign in / Sign up

Export Citation Format

Share Document